All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
• Merck & Co. Inc., of Whitehouse Station, N.J., said the FDA approved Zioptan (tafluprost ophthalmic solution) 0.0015 percent, a preservative-free prostaglandin analogue ophthalmic solution for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.